The average 340B safety-net hospital, which cares for a disproportionate share of low-income and uninsured patients, reported annual losses of $2.96 million, and the average critical access hospital lost an average of $507,000 as a result of drug company 340B restrictions, according to a survey conducted by the American Hospital Association.
Read the full post on Becker's Hospital Review - Healthcare News
